CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹258 Cr | ₹92 Cr | ₹247 Cr | ₹520 Cr | ₹824 Cr |
What is the latest Total Debt ratio of CIPLA ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹258 Cr |
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹520 Cr |
| Mar2022 | ₹824 Cr |
How is Total Debt of CIPLA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹258 Cr | 180.10 | |
| Mar2025 | ₹92 Cr | -62.72 | |
| Mar2024 | ₹247 Cr | -52.53 | |
| Mar2023 | ₹520 Cr | -36.86 | |
| Mar2022 | ₹824 Cr | - | |
Compare Total Debt of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹118,423.5 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| MANKIND PHARMA | ₹106,427.0 Cr | 2.9% | 3.5% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 3.9% |
0.6% |
0% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses